Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin

A review of the literature finds that women diagnosed with breast cancer, who were on an aspirin regimen, experienced a decreased risk of distant metastases and death. Several recent studies have reported an improvement in overall survival in colorectal cancer patients who harbored mutations in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Turturro, Sanja B., Najor, Matthew S., Ruby, Carl E., Cobleigh, Melody A., Abukhdeir, Abde M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788696/
https://www.ncbi.nlm.nih.gov/pubmed/26915040
http://dx.doi.org/10.1007/s10549-016-3729-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788696/
https://www.ncbi.nlm.nih.gov/pubmed/26915040
http://dx.doi.org/10.1007/s10549-016-3729-8

Ejemplares similares